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Introduction of a New Housekeeping Gene Sequences for
Rapid Identiﬁcation of Vibrio cholerae Strains in the Clin-
ical Samples
A. Dashtebani ∗, B. Bakhshi, M. Oskui, M.R. Pourshaﬁe
Pasteur Institute of Iran, Tehran, Iran (Islamic Republic of)
Background: Vibrio cholerae is a noninvasive, gram-
negative bacterium responsible for severe epidemics of
cholera and endemic diarrhea in many parts of the world,
especially developing countries. Vibrio cholerae strains may
produce a variety of atypical biochemical reactions which
may pose some difﬁculties in rapid identiﬁcation and recov-
ery of these bacteria from mixed samples isolated from
clinical or environmental sources. To best of our knowledge
dnaE gene is widespread among all Vibrio cholerae strains.
Our study is aimed at developing the use of PCR ampliﬁ-
cation of dnaE housekeeping gene as a screening tool for
identiﬁcation of Vibrio cholerae among mixed clinical sam-
ples and comparison with the time consuming conventional
biochemical methods.
Methods: A total of 24 Vibrio cholerae isolates of clinical
origin isolated and subjected to serogrouping and subse-
quent PCR analysis using primers which speciﬁcally chosen
to amplify within the dnaE gene in the genome of the Vibrio
cholerae isolates. Vibrio cholerae ATCC 14035 and Pseu-
domonas aeruginosa ATCC 27853 were used as positive and
negative controls in each assay
Results: Among 24 Vibrio cholerae isolated, 21% identi-
ﬁed as Ogawa and the remaining 79% as Inaba serogroup.
PCR analysis of the dnaE housekeeping gene revealed the
presence of this gene in 100% of isolates examined and
approximately 300 bp product was obtained from the iso-
lates. The identity of the product was further conﬁrmed
using RFLP assay
Conclusions: The result of this study suggest the use of
dnaE housekeeping gene as a molecular marker for rapid
identiﬁcation of Vibrio cholerae in mixed clinical samples.
doi:10.1016/j.ijid.2008.05.1316
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Bacterial DNA Load in Cerebrospinal Fluid During Treat-
ment of Bacterial Meningitis
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1 Oxford University Clinical Research Unit, Ho Chi Minh,
Vietnam
2 Hospital for Tropical Diseases, Ho Chi Minh, Vietnam
Background: Bacterial meningitis is an important cause
of morbidity and mortality in Vietnam. The diagnosis can be
difﬁcult to establish, e.g. due to frequent pretreatment with
antimicrobial agents. We developed a quantitative real-time
PCR (qRT-PCR) to determine the bacterial DNA load in CSF
during treatment of four major pathogens causing bacterial
meningitis in Vietnam.
Methods:CSF samples were collected from 445 patients
with suspected bacterial meningitis on hospital admission,
after 48 hours, and 6—15 days after admission. Primers
and probes for detection of Steptococcus pneumoniae (Sp),
Haemophilus inﬂuenzae b (Hib) and Neisseria meningitidis
(Nm) were as described previously by Corless et al. Primers
and probe for Streptococcus suis type 2 (SS2) detection were
designed using Primer Express. PCR fragments were cloned
in TA cloning vector. Serial 10 fold-dilutions of puriﬁed plas-
mid served as external standards for real-time quantitation
Results:SS2 was detected in 149 (33.5%) of samples col-
lected on admission, Sp in 79 (17.8%), Nm in 29 (6.5%)
and Hib in 5 (1.1%) using RT-PCR. The median bacterial
DNA load on admission was 1.48× 106 DNA copies/ml (range
1.0× 103—1.1× 108) for SS2, 4.98× 105 DNA copies/ml
(range 1.0× 103—9.1× 109) for Sp, 3.37× 106 DNA copies/ml
(range 1.0× 103—1.13× 108) for Nm. Clearance of bacterial
DNA was gradual. Median bacterial DNA loads of SS2, SP and
Nm were similar at each of the sampling times. DNA was
still detectable in 69/156 (44.2%) samples collected 6—10
days after start of treatment and in 17/53 (32.07%) samples
collected after 11—15 days
Conclusions:Median bacterial DNA loads are similar in
meningitis caused by SS2, Sp and Nm but are highly vari-
able when comparing individual patients. DNA loads decline
only gradually during treatment, enabling diagnosis by PCR
even after start of antimicrobial treatment. qRT-PCR can be
used to study the association between bacterial DNA load
and clearance and outcome.
doi:10.1016/j.ijid.2008.05.1317
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A Comparative Western Immunoblot Antibody Titration
Test for Evaluation of Bartonella Therapy
W.D. Hardy Jr. ∗, E.E. Zuckerman
National Veterinary Laboratory, Inc., Franklin Lakes, NJ,
USA
Introduction: Bartonella are zoonotic pathogens mainly
transmitted by cats and occasionally dogs. They are difﬁ-
cult to isolate and most Bartonella infections of animals or
people are diagnosed by detection of coexisting antibody
(IgG).
Methods: We developed a single dilution western
immunoblot (WB) for detection of Bartonella antibodies (IgG
1:100) for determination of Bartonella spp. infection. We
adapted this test in a comparative titration format (pre
and 6 months post therapy) to assess the elimination of
Bartonella from cats, dogs and people
Results: Bartonella was isolated from 7 seropositive pet
cats before doxycycline therapy. All 7 cats were culture neg-
ative 1 month post therapy but at 6 months only 5 of the 7
cats remained culture negative. All 5 of the culture negative
cats had a titer decrease of 4 fold (n = 4) and 2 fold (n = 1)
whereas the 2 cats where Bartonella was isolated 6 months
post therapy had no titer decrease. In contrast, there was no
titer decrease in 21 untreated Bartonella-seropositive pet
cats observed for more than 1 year. 9,782 titrations were
performed on Bartonella-seropositive pet cats 6 months
after treatment with: azithromycin (n = 9,162), rifampin
(n = 469) and doxycycline (n = 151). A 2 fold titer decrease
occurred in 1,119 cats (11.4%) and a 4 fold or greater titer
decrease occurred in 7,583 cats (76.5%). Thus, post ther-
